Posted: Wed Jan 21, 2009 8:14 am
measuring flow was therapeutic?
Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/
Be careful what you wish for...wobbly wrote:any questions just ask
Welcome to our site, having you read / post here is absolutely brilliant, I am glad you found us and decided to be visible.wobbly wrote:hi all /i am 1 of 4 americans who just went 2 italy 2 have this procedure done/ it is a joint venture with the research team in buffalo
Did you actually have a procedure performed on yourself? or were you just tested?wobbly wrote:I ... have this procedure done ... but i will tell u it was no big deal... i do no that stents r in the works
I can understand your position, and if we ask questions you are not comfortable with answering, please feel free to say so.wobbly wrote:i am not really supposed 2 talk abt it
I am trying to get the tests performed on me, with the results coming out either way (ie pass or fail Zamboni criteria) I plan to send them to Zamboni; your relationship may help this process for me.wobbly wrote: however i got 2 no dr zamboni very well
Are your dopplers being performed at the Zamboni related labs in Baffalo or simply at a general sonography lab?wobbly wrote:i have mri s and dopplers 4 sat 2 check what happened
Have you or any others seen EDSS improvements? Do you know if Zamboni is preparing any results showing de-activation of MRI conditions? and no re-activations etc etc?wobbly wrote:also i feel clearer and my intense heat sensitivity has gone away 4 now
link1: Angiology. 2008 Jun-Jul;59(3):352-6. Epub 2008 Apr 2. Links
Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.Flota-Cervera F, Flota-Ruiz C, Treviño C, Berber A.
Centro de Diagnostico de Enfermedades Cardiovasculares, Merida, Yucatan, Mexico.
The aims of the present study were to investigate the effect of calcium dobesilate on lymph flow and lymphovenous edema in patients with chronic venous disease. It was a randomized, placebo-controlled, double-blind clinical trial. Patients received 1 capsule of 500 mg calcium dobesilate every 8 hours (1.5 g/day) or placebo by 49 days. By the end of the treatment period, only the patients treated with calcium dobesilate had normalization of lymphogammagraphy (capture index and speed of lymph flow; 80 and 78%, respectively). Only patients treated with calcium dobesilate had statistically significant reduction in the perimeter of leg, calf, and ankle. Twenty-two out of 25 (88%) calcium dobesilate-treated patients presented clinical improvement versus 5 out of 24 (20.8%) in the placebo group. One patient on calcium dobesilate developed rash and one patient on placebo complained of vomiting. In the present study, calcium dobesilate normalized lymph physiology and improved symptoms in patients with chronic venous disease.
PMID: 18388097 [PubMed - indexed for MEDLINE]
The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis
Paolo Zamboni, Erica Menegatti, Roberto Galeotti, Anna Maria Malagoni, Giovanna Tacconi, Sergio Dall'Ara, Ilaria Bartolomei1, Fabrizio Salvi1
Received 14 September 2008; received in revised form 25 November 2008; accepted 27 November 2008. published online 14 January 2009.
Corrected Proof
Abstract
Iron stores in the white and deep grey matter in course of multiple sclerosis (MS) have never been explained and could be related to abnormalities in venous drainage, but this possibility has never before been investigated.
From an initial cohort of 320 subjects, after application of exclusion criteria, we selected 109 patients affected by MS, and 177 controls respectively composed by age- and sex-matched, healthy aged, and patients affected by other neurological diseases. They blindly underwent transcranial and extracranial Color–Doppler sonographic examination (TCCS-ECD), aimed at investigating five parameters related to normal cerebral venous outflow haemodynamics.
Overall we analyzed 1430 TCSS-ECD parameters. In controls we found 861 normal parameters of cerebral venous return vs. 24 anomalous, whereas in MS 288 parameters were normal and 257 anomalous, respectively. Consequently, each of the considered Doppler haemodynamic parameters, when compared to revised McDonald criteria as a gold standard of MS diagnosis, showed separately a highly significant sensitivity and a noteworthy specificity. However, the detection ≥2 parameters in the same subject, never observed in controls, perfectly overlapped the diagnosis of MS (value, 95%CI: sensitivity 100%, 97–100; specificity 100%, 98–100; positive predictive value 100%, 97–100, negative predictive value 100%, 98–100; p<0.0001). Moreover, this study demonstrates a significant impairment of cerebral venous drainage in patients affected by MS, a mechanism potentially related to increased iron stores
Thanks for sharing with us your personal experiences Wobbly, although we - here in Greece - are quite close to Zamboni's team it's big decision to go for the surgery or isn't this what you have done?wobbly wrote:hi all--had follow up mri s and doppler sat/ got nothing abt mri but my veins in my neck as per the tech looked amazingly good compared 2 the doppler b4 the procedure more 2 come as it comes HOPE